Evogene Schedules Third Quarter 2025 Financial Results Release
Rhea-AI Summary
Evogene (NASDAQ: EVGN) will release its third quarter 2025 financial results on Thursday, November 20, 2025. Company management will host a Zoom conference call the same day at 9:00 AM ET (4:00 PM Israel time) to discuss the results. Investors must register in advance to attend: https://www.veidan-conferencing.com/evogene. The full conference will be available on the company website a few days after the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, EVGN declined 1.69%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET
REHOVOT,
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To attend the conference, please register in advance:
https://www.veidan-conferencing.com/evogene
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.
At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs.
Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".
Learn more at: www.evogene.com.
Logo: https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg
Contact:
ir@evogene.com
+972-8-9311901
View original content to download multimedia:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2025-financial-results-release-302607252.html
SOURCE Evogene